BACKGROUND Advances in burn care over the past 50 years have brought about remarkable improvement in mortality rates such that survival has become an expected outcome even in patients with extensive injuries. Although these improvements have occurred in all age groups, survival in older adults still lags far behind that in younger cohorts. This study determines the outcomes of older adults with...

Abstract Background Royston-Parmar flexible parametric survival models (FPMs) can be fitted on either the cause-specific hazards or cumulative incidence scale in presence of competing risks. An advantage modelling within this framework for risks data is ease at which alternative predictions to (cause-specific subdistribution) hazard ratio obtained. Restricted mean time (RMST), restricted failur...

A RECENT study of survivorship among the blind in Massachusetts [1] reveals that blind persons under 65 suffering from retrolental fibroplasia had a significantly better survivorship than other blind individuals . This may be the result of a pineal effect upon longevity . Ten year survival rates for major affections in the Massachusetts study (see Table 1) reveal that blind males under 65 with ...

CONTEXT Multiple comprehensive, risk-adjusted studies evaluating short-term surgical mortality have been reported previously. This report analyzes short-term and long-term outcomes, both nationally and at each individual transplant program, for all solid organ transplantations performed in the United States. OBJECTIVES To report graft and patient survival rates for all solid organ transplanta...

Introduction: The hypoxic state, in which experimental animals were subjected to an atmosphere of 5% O2 and %95 N2, has been used to screen agents for possible cerebral protection by measuring their ability to prolong survival time in mice exposed to hypoxia. Researchers showed that rimonabant and AM251 allosteric potentiate all but the β1 subunit containing GABAA receptors at nM...

Purpose: A meta-analysis of randomized trials in advanced ovarian cancer showed a longer survival with cyclophosphamide, doxorubicin, and cisplatin (CAP) than with cyclophosphamide and cisplatin (CP; P .009). In contrast, the results of the large International Collaborative Ovarian Neoplasm Study (ICON2) showed no survival difference between CAP and carboplatin (P .98). In this article, we show...

Abstract Passes are by far football’s (soccer) most frequent event, yet surprisingly little meaningful research has been devoted to quantify them. With the increase in availability of so-called positional data, describing positioning players and ball at every moment game, our work aims determine difficulty pass calculating its success probability based on surrounding circumstances. As experts w...

OBJECTIVES To provide reference expected cumulative survival tables, reducing steps in the calculation of mortality ratios and excess death rates from the medical literature, when source data are in terms of survival curves or cumulative survival rates. METHOD Actuarial methodology. RESULTS Tables provide cumulative expected survival rates calculated by entry age and for different periods o...